411 studies found for:    Open Studies | "Nevus"
Show Display Options
Rank Status Study
21 Recruiting Potential Research Study Participant Registry
Conditions: Acne;   Actinic Keratosis;   Dysplastic Nevi;   Eczema;   Psoriasis;   Skin Cancer;   Rosacea;   Leg Ulcers;   Foot Ulcers;   Atopic Dermatitis
Intervention:
22 Unknown  Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Condition: Melanoma
Intervention:
23 Recruiting FLuorescence Identification of Melanoma by a Multicenter Based Algorithm (FLIMMA)
Conditions: Melanoma;   Moles
Intervention: Device: LIMES
24 Recruiting Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
Conditions: Burn Injury;   Soft Tissue Injury;   Skin Necrosis;   Scars;   Congenital Giant Nevus;   Skin Tumors
Interventions: Other: denovoDerm;   Other: denovoSkin
25 Recruiting Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
Conditions: Choriocarcinoma;   FIGO Stage I Gestational Trophoblastic Tumor;   FIGO Stage II Gestational Trophoblastic Tumor;   FIGO Stage III Gestational Trophoblastic Tumor;   Hydatidiform Mole
Interventions: Biological: Dactinomycin;   Drug: Leucovorin Calcium;   Drug: Methotrexate;   Other: Quality-of-Life Assessment
26 Recruiting Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Other: No relevant intervention.
27 Unknown  Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Condition: Ocular Melanoma
Intervention:
28 Recruiting Scalp Nerve Block on Emergence Agitation
Condition: Agitation
Interventions: Drug: Ropivacaine;   Drug: Remifentanil;   Drug: Sevoflurane
29 Recruiting Erismodegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Conditions: Basal Cell Carcinoma of the Skin;   Nevoid Basal Cell Carcinoma Syndrome;   Recurrent Skin Cancer
Interventions: Drug: buparlisib;   Drug: erismodegib;   Other: laboratory biomarker analysis;   Other: questionnaire administration
30 Recruiting Study of Selected X-linked Disorders: Goltz Syndrome
Conditions: Focal Dermal Hypoplasia (FDH);   Goltz Syndrome;   X Linked Disorders
Intervention:
31 Unknown  (Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic Groups
Conditions: Insulin Resistance;   Type 2 Diabetes Mellitus;   Cardiovascular Diseases
Intervention:
32 Recruiting Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia
Conditions: Gestational Trophoblastic Disease;   Gestational Trophoblastic Neoplasia;   Gestational Trophoblastic Tumor;   Gestational Trophoblastic Neoplasms
Interventions: Drug: MTX 1;   Drug: MTX 2;   Biological: Act-d
33 Recruiting Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease
Condition: Trophoblastic Neoplasms
Interventions: Drug: chemotherapy agents;   Procedure: suction curettage
34 Recruiting Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Stable or Slowly Progressing Disease.
Condition: Metastatic Melanoma
Intervention: Drug: TLPLDC Vaccine
35 Recruiting Percutaneous Hepatic Perfusion vs Best Alternative Care in Patients With Hepatic-dominant Ocular Melanoma
Condition: Melanoma, Ocular
Interventions: Procedure: Melphalan;   Procedure: TACE;   Drug: Dacarbazine;   Drug: Ipilimumab;   Drug: Pembrolizumab
36 Not yet recruiting Phase 1 Study of IMP321 Adjuvant to Anti-PD-1 Therapy in Unresectable or Metastatic Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma
Interventions: Drug: IMP321;   Drug: Pembrolizumab
37 Recruiting Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma
Condition: Malignant Melanoma
Intervention:
38 Not yet recruiting A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients
Condition: Melanoma
Intervention: Drug: SHR6390
39 Not yet recruiting Employment and Quality of Life in Patients With Malignant Melanoma
Conditions: Malignant Melanoma of Skin;   Quality of Life;   Work Ability
Intervention: Behavioral: Quality of Life, status of employment
40 Recruiting A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM)
Condition: Advanced Melanoma
Intervention: Drug: Pembrolizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years